DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
LUFOTRELVIR
1
Small molecule
Investigational
Unknown
Unknown
Virus Diseases
Unknown
LUFOTRELVIR
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C24H33N4O9P
Molecular Weight:
552.52
AlogP:
1.01
PSA:
196.15
HBD:
6.0
HBA:
#RotB:
13.0
Source:
GLUCAGON-LIKE PEPTIDE 1
1
Protein
Investigational
Unknown
Unknown
Heart Failure
Unknown
GLUCAGON-LIKE PEPTIDE 1
×
Maximum Phase:
1
First Approval:
None
UNII:
SQ6SA9L9XQ
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SONTUZUMAB
1
Antibody
Investigational
Unknown
Unknown
Unknown
Mucin-1 other
SONTUZUMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CARBENDAZIM
1
Small molecule
Investigational
Unknown
Unknown
Lymphoma; Neoplasms
Unknown
CARBENDAZIM
×
Maximum Phase:
1
First Approval:
None
UNII:
H75J14AA89
Molecule Type:
Small molecule
Molecular Formula:
C9H9N3O2
Molecular Weight:
191.19
AlogP:
1.74
PSA:
67.01
HBD:
2.0
HBA:
#RotB:
1.0
Source:
PLAZINEMDOR
1
Unknown
Investigational
Unknown
Unknown
Schizophrenia
Unknown
PLAZINEMDOR
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TIBULIZUMAB
1
Antibody
Investigational
Unknown
Unknown
Arthritis, Rheumatoid; Sjogren's Syndrome
Interleukin 17A inhibitor
TIBULIZUMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
42HQ15W1ZF
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BALAFILCON A
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
BALAFILCON A
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FS-102
1
Unknown
Investigational
Unknown
Unknown
Neoplasms
Unknown
FS-102
×
Maximum Phase:
1
First Approval:
None
UNII:
Z27ZI1MZY9
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
COM-701
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
COM-701
×
Maximum Phase:
1
First Approval:
None
UNII:
IAY02XUV7L
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SALVINORIN A
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
SALVINORIN A
×
Maximum Phase:
1
First Approval:
None
UNII:
T56W91NG6J
Molecule Type:
Small molecule
Molecular Formula:
C23H28O8
Molecular Weight:
432.47
AlogP:
3.0
PSA:
109.11
HBD:
0.0
HBA:
#RotB:
3.0
Source:
GAMMA-AMINOBUTYRIC ACID
1
Small molecule
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 1; Epilepsy
Unknown
GAMMA-AMINOBUTYRIC ACID
×
Maximum Phase:
1
First Approval:
None
UNII:
2ACZ6IPC6I
Molecule Type:
Small molecule
Molecular Formula:
C4H9NO2
Molecular Weight:
103.12
AlogP:
-0.19
PSA:
63.32
HBD:
2.0
HBA:
#RotB:
3.0
Source:
ADCT-602
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
ADCT-602
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AMMONIUM TRICHLORO(DIOXOETHYLENE-O,O'-)TELLURATE
1
Small molecule
Investigational
Unknown
Unknown
HIV Infections
Unknown
AMMONIUM TRICHLORO(DIOXOETHYLENE-O,O'-)TELLURATE
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C2H8Cl3NO2Te
Molecular Weight:
312.05
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
HE3235
1
Small molecule
Investigational
Unknown
Unknown
Prostatic Neoplasms, Castration-Resistant
Androgen Receptor modulator
HE3235
×
Maximum Phase:
1
First Approval:
None
UNII:
891O182ZP5
Molecule Type:
Small molecule
Molecular Formula:
C21H32O2
Molecular Weight:
316.49
AlogP:
3.75
PSA:
40.46
HBD:
2.0
HBA:
#RotB:
0.0
Source:
CT-7001
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
CT-7001
×
Maximum Phase:
1
First Approval:
None
UNII:
46D4HS9ODA
Molecule Type:
Small molecule
Molecular Formula:
C22H30N6O
Molecular Weight:
394.52
AlogP:
2.85
PSA:
86.51
HBD:
4.0
HBA:
#RotB:
7.0
Source:
PLAMOTAMAB
1
Antibody
Investigational
Unknown
Unknown
Leukemia, Lymphocytic, Chronic, B-Cell
Unknown
PLAMOTAMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
5ENX424FNF
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BMS-986318
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
BMS-986318
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SERDEMETAN
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
SERDEMETAN
×
Maximum Phase:
1
First Approval:
None
UNII:
ID6YB4W3V8
Molecule Type:
Small molecule
Molecular Formula:
C21H20N4
Molecular Weight:
328.42
AlogP:
4.96
PSA:
52.74
HBD:
3.0
HBA:
#RotB:
6.0
Source:
LMB-7
1
Antibody
Investigational
Unknown
Unknown
Central Nervous System Neoplasms
Lewis Y antigen binding agent
LMB-7
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PF-05241328
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
PF-05241328
×
Maximum Phase:
1
First Approval:
None
UNII:
8RAL5N48VT
Molecule Type:
Small molecule
Molecular Formula:
C19H21ClN4O4S
Molecular Weight:
436.92
AlogP:
3.11
PSA:
103.18
HBD:
1.0
HBA:
#RotB:
6.0
Source:
PHA-793887
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Cyclin-dependent kinase inhibitor
PHA-793887
×
Maximum Phase:
1
First Approval:
None
UNII:
MKS45S912B
Molecule Type:
Small molecule
Molecular Formula:
C19H31N5O2
Molecular Weight:
361.49
AlogP:
2.31
PSA:
81.33
HBD:
2.0
HBA:
#RotB:
4.0
Source:
NORCANTHARIDIN
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
NORCANTHARIDIN
×
Maximum Phase:
1
First Approval:
None
UNII:
8452E71EO7
Molecule Type:
Small molecule
Molecular Formula:
C8H8O4
Molecular Weight:
168.15
AlogP:
-0.14
PSA:
52.6
HBD:
0.0
HBA:
#RotB:
0.0
Source:
SGN-CD352A
1
Unknown
Investigational
Unknown
Unknown
Multiple Myeloma
Unknown
SGN-CD352A
×
Maximum Phase:
1
First Approval:
None
UNII:
ZX1I49XP7L
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ZAMPILIMAB
1
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
ZAMPILIMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
52B38H09GZ
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FRIULIMICIN B
1
Protein
Investigational
Unknown
Unknown
Unknown
Unknown
FRIULIMICIN B
×
Maximum Phase:
1
First Approval:
None
UNII:
AYO43961I1
Molecule Type:
Protein
Molecular Formula:
C59H94N14O19
Molecular Weight:
1303.48
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
RALIMETINIB
1
Small molecule
Investigational
Unknown
Unknown
Fallopian Tube Neoplasms; Glioblastoma; Neoplasms; Ovarian Neoplasms; Breast Neoplasms
MAP kinase p38 alpha inhibitor
RALIMETINIB
×
Maximum Phase:
1
First Approval:
None
UNII:
73I34XW4HD
Molecule Type:
Small molecule
Molecular Formula:
C24H29FN6
Molecular Weight:
420.54
AlogP:
5.55
PSA:
85.41
HBD:
2.0
HBA:
#RotB:
3.0
Source:
LY03005
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
LY03005
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TRICETAMIDE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Tyrosine-protein kinase JAK1 inhibitor
TRICETAMIDE
×
Maximum Phase:
1
First Approval:
None
UNII:
V6X0RFU7AF
Molecule Type:
Small molecule
Molecular Formula:
C16H24N2O5
Molecular Weight:
324.38
AlogP:
1.31
PSA:
77.1
HBD:
1.0
HBA:
#RotB:
8.0
Source:
CIAFTALAN
1
Small molecule
Investigational
Unknown
Unknown
Mycosis Fungoides; Sezary Syndrome
Unknown
CIAFTALAN
×
Maximum Phase:
1
First Approval:
None
UNII:
V5PUF4VLGY
Molecule Type:
Small molecule
Molecular Formula:
C32H18N8
Molecular Weight:
514.55
AlogP:
6.87
PSA:
108.92
HBD:
2.0
HBA:
#RotB:
0.0
Source:
UNESBULIN
1
Small molecule
Investigational
Unknown
Unknown
Diffuse Intrinsic Pontine Glioma; Leiomyosarcoma; Neoplasms; Ovarian Neoplasms
Unknown
UNESBULIN
×
Maximum Phase:
1
First Approval:
None
UNII:
Z4HZ70S62Q
Molecule Type:
Small molecule
Molecular Formula:
C19H13F5N6
Molecular Weight:
420.35
AlogP:
4.75
PSA:
81.65
HBD:
2.0
HBA:
#RotB:
3.0
Source:
INULINE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
INULINE
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C32H46N2O8
Molecular Weight:
586.73
AlogP:
1.72
PSA:
132.94
HBD:
3.0
HBA:
#RotB:
8.0
Source:
NERINDOCIANINE
1
Small molecule
Investigational
Unknown
Unknown
Wounds and Injuries
Unknown
NERINDOCIANINE
×
Maximum Phase:
1
First Approval:
None
UNII:
1GZ5G85KVT
Molecule Type:
Small molecule
Molecular Formula:
C44H52N2O16S5
Molecular Weight:
1025.23
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED)
1
Small molecule
Investigational
Unknown
Unknown
Acquired Immunodeficiency Syndrome
Unknown
CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED)
×
Maximum Phase:
1
First Approval:
None
UNII:
HHT01ZNK31
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MRA 003 US
1
Antibody
Investigational
Unknown
Unknown
Lupus Erythematosus, Systemic
Interleukin-6 inhibitor
MRA 003 US
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
D-3263
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Transient receptor potential cation channel subfamily M member 8 agonist
D-3263
×
Maximum Phase:
1
First Approval:
None
UNII:
70FBL3TX3E
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
1
2
…
75
76
77
78
79
80
81
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA